TickerFactsScreenerDevelopers

ORAMED PHARMACEUTICALS INC. (ORMP) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2011: -$1.71M2012: -$2.30M2013: -$3.40M2014: -$4.07M2015: -$4.95M2016: $4.66M2017: -$5.83M2018: -$14.66M2019: -$12.94M2020: -$12.44M2021: -$21.18M2022: -$27.92M2023: -$10.29M2024: -$8.41M2025: -$9.14M-$9.14M
2011Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$9.14M-8.7%
2024-$8.41M+18.3%
2023-$10.29M+63.1%
2022-$27.92M-31.8%
2021-$21.18M-70.3%
2020-$12.44M+3.9%
2019-$12.94M+11.7%
2018-$14.66M-151.4%
2017-$5.83M-225.3%
2016$4.66M+194.1%
2015-$4.95M-21.6%
2014-$4.07M-19.8%
2013-$3.40M-47.6%
2012-$2.30M-34.9%
2011-$1.71M—